Beijing Beilu Pharmaceutical Co., Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 183.93 million compared to CNY 222.08 million a year ago. Revenue was CNY 183.93 million compared to CNY 222.08 million a year ago. Net income was CNY 39.26 million compared to CNY 50.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.08 compared to CNY 0.1032 a year ago.